VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety and efficacy of VEC-162 compared to placebo to improve sleep parameters in a model of insomnia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Vanda Pharmaceuticals

Criteria

Inclusion Criteria:

• Healthy subjects with no medical, psychiatric or current sleep disorders.

• Subject must sign a written consent form.

Exclusion Criteria:

• Recent history of night shift work or jet lag.

• Prior experience sleeping in a sleep lab environment.

• History of sleep disorders.